National Biotechnology and Biomanufacturing Initiative
National Biotechnology and Biomanufacturing Initiative

Discover the Surprising Dual Nature of One Bacterium
🔍 Researchers discover a bacterium with dual nature: harmful in hospitals, but with potential in dyeing fabrics and medicine. 🧫💉🌈

Fujifilm Invests $12B to Create Massive Biopharmaceutical Facility in North Carolina
📢 Fujifilm invests $1.2B to expand North Carolina CDMO, adding 8 bioreactors and becoming a top biopharmaceutical facility. 🏭💰💼🌍

Unlocking the Power of Industrial IoT in Bioprocessing
📰 The Industrial Internet of Things (IIoT) is revolutionizing bioprocessing, offering better control and streamlined regulatory submissions. 💪💰

Revolutionary Proteins Transform Nutrient Monitoring in Biopharma
🔍 Researchers have developed a potential alternative technology for nutrient monitoring in biopharma using periplasmic binding proteins. 💡

Revolutionizing Bioprocessing with Integrated Microfluidics
📝 Bioprocessing can benefit from the integration of microfluidic devices, similar to how integrated circuits transformed computing. 🌡️ Microfluidics offer advantages such as testing multiple variables quickly and using low reagent levels. 🧪 Researchers developed an integrated microfluidic device for continuous bioprocessing, allowing for the screening and optimization of multiple conditions. 🔬 The device demonstrated consistent production of green fluorescent protein (GFP) over eight days. ⏱️ Integrated microfluidic devices have the potential to revolutionize biomanufacturing with rapid screening and optimization capabilities.

AstraZeneca Acquires Amolyt Pharma for $105bn!
📢 AstraZeneca to acquire Amolyt Pharma for $1.05bn 💼💰 with $800m upfront and potential milestone payments of $250m. Amazing news for biotech in France and Europe!

IIT Madras Teams Up with Vellon Space to Revolutionize Biomanufacturing in Space
🚀 IIT Madras partners with Vellon Space to advance biomanufacturing in microgravity, revolutionizing cell culture in space.

Agathos Launches Game-Changing rAAV Service: Ethical Cell Line Revolutionizes Biomanufacturing
🔍 Agathos Biologics launches rAAV production service using AE1-BHK cell line, records first sale to Genovac. 💡✅🔬🌐

Revolutionizing Biomolecular Studies with Innovative Technologies
🔍 Re-Imagining Surface Plasmon Resonance for Characterizing Biomolecular Interactions explores innovative technologies to enhance lab accessibility. 🧪💻

Revolutionizing Vaccines: Innovation and Flexibility are Vital
🌍💉 The vaccine sector needs innovative technology and regulatory flexibility to thrive, says industry group Vaccines Europe. 💪🔬🚀✨





